Erloted belongs to an antineoplastic class of medication. It is used to treat non-small cell lung cancer and pancreatic cancer (locally advanced or spread to other body areas).
Erloted attaches to the chemical messenger epidermal growth factor receptors and stops the action of an abnormal protein that enables the cancer cells to multiply. Thus it regulates the growth of the cancer cells.
Non-small cell lung cancer is one of two leading kinds of cancer. It impacts both smokers and nonsmokers. Do not smoke, and avoid alcohol if you have this condition. Drink plenty of fluids.
Pancreatic cancer is a condition where there will be unusual growth of cells in pancreatic tissue. Erloted regulates the chemicals responsible for abnormal pancreas cell growth and helps reduce symptoms attributed to pancreatic cancer like appetite loss or weight loss.
This medicine is not safe to use in pregnancy. Males must inform their doctor if their partner intends to be pregnant as it leads to abnormality. Use effective contraception methods to avoid pregnancy. This medicine is not safe to use while breastfeeding. Avoid breastfeeding up to 2 weeks after your final dose. Do not use excess dose than the recommended dose.
This medicine's most common side effects are abdominal pain, bone pain, breathlessness, constipation, cough, diarrhoea, fatigue, fever, infection, muscle pain, nausea, rash, stomatitis, vomiting, and weight loss. If the symptoms persist or worsen your condition, you need to consult your doctor immediately.
